Sulis Therapeutics ApS — Credit Rating and Financial Key Figures
CVR number: 44445832
Inge Lehmanns Gade 10, 8000 Aarhus C
Income statement (kEUR)
2023 | |
|---|---|
| Fiscal period length | 12 |
| Net sales | |
| Gross profit | -2.01 |
| Total depreciation | -2.53 |
| EBIT | -4.54 |
| Pre-tax profit | -4.54 |
| Net earnings | -4.54 |
Assets (kEUR)
2023 | |
|---|---|
| Intangible rights | 149.10 |
| Intangible assets total | 149.10 |
| Tangible assets total | |
| Investments total | |
| Long term receivables total | |
| Inventories total | |
| Current other receivables | 37.91 |
| Short term receivables total | 37.91 |
| Cash and bank deposits | 9.39 |
| Cash and cash equivalents | 9.39 |
| Balance sheet total (assets) | 196.39 |
Equity and liabilities (kEUR)
2023 | |
|---|---|
| Share capital | 13.42 |
| Retained earnings | 147.60 |
| Profit of the financial year | -4.54 |
| Shareholders equity total | 156.48 |
| Non-current liabilities total | |
| Current trade creditors | 39.92 |
| Current liabilities total | 39.92 |
| Balance sheet total (liabilities) | 196.39 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.